Human IL-13 R alpha 2 Antibody, R&D Systems™

IL-13R alpha 2

Polyclonal

Unconjugated

Q14627

IL13RA2

Mouse myeloma cell line NS0-derived recombinant human IL-13 R alpha 2 Cys22-Leu342 Accession # Q14627

100 μg

Primary

Detects human IL-13 R alpha 2 in direct ELISAs and Western blots. In direct ELISAs, approximately 5% cross-reactivity with recombinant mouse IL-13 R alpha 2 is observed and less than 1% cross-reactivity with recombinant human IL-13 R alpha 1 is observed.

Human

IgG

Western Blot, Flow Cytometry, Immunohistochemistry, Blockade of Receptor-ligand Interaction

LYOPH

Western Blot 0.2 ug/mL, Simple Western 10 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Immunohistochemistry 5-15 ug/mL, Blockade of Receptor-ligand Interaction, CyTOF-ready

cancer/testis antigen 19, CD213a2, CD213a2 antigen, CT19, IL-13 receptor subunit alpha-2, IL13BP, IL13R, IL-13R, IL13R alpha 2, IL-13R subunit alpha-2, IL13RA2, IL-13RA2, IL-13R-alpha-2, interleukin 13 binding protein, interleukin 13 receptor alpha 2 chain, interleukin 13 receptor, alpha 2, interleukin-13 receptor subunit alpha-2, Interleukin-13-binding protein

Goat

Affinity Purified

RUO

3598

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.